Zenas BioPharma (NASDAQ:ZBIO) announced its full-year 2025 financial results on March 16, 2026, marking a pivotal year that has positioned the Waltham, Massachusetts-based biotech for its first potential product launch.
Contango ORE (NYSE:CTGO) filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, detailing the company's successful transition from explorer to producer.
Anna Edwards, Lizzy Burden, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
UniCredit made a 35 billion ($40 billion) bid for Commerzbank that will allow it to increase its shareholding beyond 30%, easing the path for a potential future acquisition. Bloomberg's Tommaso Ebhardt reports.
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
Global energy markets are reeling as oil tracks toward its most significant weekly gain in four years, fuelled by escalating conflict in the Middle East.
Global oil prices held steady on March 3 as energy markets braced for an intensification of conflict in the Middle East.
U.S. Customs and Border Protection (CBP) will officially stop collecting billions in trade duties at 12:01 a.m. EST on Tuesday, following a landmark Supreme Court ruling that declared President Donald Trump’s use of emergency powers to levy tariffs illegal.
"The companies do not have an interest right now, nor is there enough money for insurance to transit those ships through the Strait," says Port of Los Angeles Executive Director Gene Seroka as he discusses shipping disruptions related to the Iran War and the Strait of Hormuz.
The Buckle (NYSE:BKE) delivered a solid conclusion to its 2025 fiscal year, posting gains in both top-line revenue and net income as the denim-focused retailer continues to navigate a shifting consumer landscape.
Adobe (NASDAQ:ADBE) shares plummeted on Friday, wiping out billions in market value after the creative software giant announced that Shantanu Narayen will step down as Chief Executive Officer.
Waldencast (NASDAQ:WALD) reported a transformative finish to fiscal year 2025, prioritizing balance sheet stability through a series of strategic divestitures and debt restructurings while navigating mixed performance across its core brand portfolio.
Kyivstar Group (NASDAQ:KYIV), the first Ukrainian company to list on the Nasdaq, delivered a robust performance for fiscal year 2025, signaling that its evolution into a diversified digital operator is successfully offsetting the challenges of a volatile operating environment.
Immutep (NASDAQ:IMMP) announced on March 13, 2026, that it will shut down its Phase III TACTI-004 clinical trial evaluating eftilagimod alpha ("efti") in combination with anti-PD-1 therapy for first-line non-small cell lung cancer (NSCLC).
-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)
